4//SEC Filing
Davis Blaine 4
Accession 0001209191-20-008531
CIK 0001359931other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:51 PM ET
Size
5.5 KB
Accession
0001209191-20-008531
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-11+94,000→ 94,000 totalExercise: $37.30Exp: 2030-02-10→ Common Stock (94,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vesting upon Mr. Davis's completion of one year of service measured from the grant date and the balance of the shares vesting monthly thereafter for the next three years.
Documents
Issuer
ArTara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001802188
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:51 PM ET
- Size
- 5.5 KB